Going Concern (Details Narrative) - USD ($)	3 Months Ended		119 Months Ended
	Jun. 30, 2015	Mar. 31, 2015	Jun. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Non-cash gain upon deconsolidation ofEntest Biomedical, Inc.			$ 41,645,688
Net Losses			30,586,221
Equity in Net Losses of Entest Biomedical, Inc.			$ 663,649
Proceeds from issuance of convertible debt	$ 90,000	$ 775,000